Characterization and Clinical Impact of Bloodstream Infection Caused by Carbapenemase-Producing Enterobacteriaceae in Seven Latin American Countries
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Characterization and Clinical Impact of Bloodstream Infection Caused by Carbapenemase-Producing Enterobacteriaceae in Seven Latin American Countries
Authors
Keywords
Antibiotics, Enterobacteriaceae, Death rates, Bloodstream infections, Bacteremia, Enterobacter infections, Latin American people, Polymyxins
Journal
PLoS One
Volume 11, Issue 4, Pages e0154092
Publisher
Public Library of Science (PLoS)
Online
2016-04-23
DOI
10.1371/journal.pone.0154092
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Treatment of KPC-producing Enterobacteriaceae: suboptimal efficacy of polymyxins
- (2015) M.S. de Oliveira et al. CLINICAL MICROBIOLOGY AND INFECTION
- Epidemiology of Carbapenem-Resistant Enterobacteriaceae in 7 US Communities, 2012-2013
- (2015) Alice Y. Guh et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Global dissemination of extensively drug-resistant carbapenemase-producing Enterobacteriaceae: clinical perspectives on detection, treatment and infection control
- (2015) T. Tängdén et al. JOURNAL OF INTERNAL MEDICINE
- Carbapenemase-Producing Klebsiella pneumoniae Bloodstream Infections: Lowering Mortality by Antibiotic Combination Schemes and the Role of Carbapenems
- (2014) George L. Daikos et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evolución de la resistencia antimicrobiana de bacilos Gram negativos en unidades de cuidados intensivos en Colombia
- (2013) Cristhian Hernández-Gómez et al. Biomedica
- Prevalencia de bacterias Gram negativas portadoras del gen blaKPC en hospitales de Colombia
- (2013) Robinson Pacheco et al. Biomedica
- Susceptibility rates in Latin American nations: report from a regional resistance surveillance program (2011)
- (2013) Ronald N. Jones et al. Brazilian Journal of Infectious Diseases
- Infections caused by carbapenem-resistant Klebsiella pneumoniae among patients in intensive care units in Greece: a multi-centre study on clinical outcome and therapeutic options
- (2013) F. Kontopidou et al. CLINICAL MICROBIOLOGY AND INFECTION
- Current status of carbapenemases in Latin America
- (2013) Juan J Maya et al. Expert Review of Anti-Infective Therapy
- Impact of carbapenem resistance on the outcome of patients' hospital-acquired bacteraemia caused by Klebsiella pneumoniae
- (2013) K. Hussein et al. JOURNAL OF HOSPITAL INFECTION
- Carbapenemase-producing Enterobacteriaceae: Overview of a major public health challenge
- (2013) P. Nordmann MEDECINE ET MALADIES INFECTIEUSES
- Treatment Outcome of Bacteremia Due to KPC-Producing Klebsiella pneumoniae: Superiority of Combination Antimicrobial Regimens
- (2012) Zubair A. Qureshi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Emergence of Klebsiella pneumoniae Coharboring KPC and VIM Carbapenemases in Colombia
- (2012) L. J. Rojas et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy
- (2012) M. Tumbarello et al. CLINICAL INFECTIOUS DISEASES
- Bacteraemia due to OXA-48-carbapenemase-producing Enterobacteriaceae: a major clinical challenge
- (2012) C. Navarro-San Francisco et al. CLINICAL MICROBIOLOGY AND INFECTION
- Carbapenemases in Klebsiella pneumoniae and Other Enterobacteriaceae: an Evolving Crisis of Global Dimensions
- (2012) L. S. Tzouvelekis et al. CLINICAL MICROBIOLOGY REVIEWS
- Bloodstream infections caused by carbapenemase-producingKlebsiella pneumoniae: a clinical perspective
- (2012) George L Daikos et al. Expert Review of Anti-Infective Therapy
- Laboratory Detection of Enterobacteriaceae That Produce Carbapenemases
- (2012) D. Doyle et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment
- (2011) O. Zarkotou et al. CLINICAL MICROBIOLOGY AND INFECTION
- Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections
- (2011) D. Ben-David et al. CLINICAL MICROBIOLOGY AND INFECTION
- Treatment and outcomes in carbapenem-resistant Klebsiella pneumoniae bloodstream infections
- (2011) Elizabeth A. Neuner et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Carbapenem-Resistant Klebsiella pneumoniae in Post-Acute-Care Facilities in Israel
- (2011) Debby Ben-David et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Controlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection control
- (2010) Y. Carmeli et al. CLINICAL MICROBIOLOGY AND INFECTION
- Bloodstream Infections Caused by Metallo-β-Lactamase/Klebsiella pneumoniae Carbapenemase–Producing K. pneumoniae among Intensive Care Unit Patients in Greece: Risk Factors for Infection and Impact of Type of Resistance on Outcomes
- (2010) Eleni Mouloudi et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Prospective Observational Study of the Impact of VIM-1 Metallo- -Lactamase on the Outcome of Patients with Klebsiella pneumoniae Bloodstream Infections
- (2009) G. L. Daikos et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Risk Factors and Clinical Impact of Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae
- (2009) Leanne B. Gasink et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Attributable Mortality Rate for Carbapenem-Resistant Klebsiella pneumoniae Bacteremia
- (2009) Abraham Borer et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Outcomes of Carbapenem-Resistant Klebsiella pneumoniae Infection and the Impact of Antimicrobial and Adjunctive Therapies
- (2008) Gopi Patel et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started